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mesenteric ischemia. Access site complications occurred in 2 patients (7.7%).
Conclusions: Submassive pulmonary embolism ha excellent results with catheter
directed thrombolysis, however additional mechanical thrombectomy and angioplasty
is necessary in several patients to achive good clinical outcome.
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Background: Massive Pulmonary Embolism (MPE) is an important cause of death
around the world. In unstable patients (pts), Percutaneous Rheolytic Thrombectomy
(PRT) is a treatment option, especially in those unable for surgical thrombectomy or
with absolute contraindications for ﬁbrinolysis. We are reporting retrospective in-
hospital and late outcome of unstable pts treated with PRT.
Methods: Between December 2009 and April 2013 in two university Hospitals in
Buenos Aires, Argentina, we included 14 consecutive pts with MPE according to the
American College of Chest Physicians guidelines and conﬁrmed by multislice
computed tomography and doppler ultrasound (US), moderate to severe right ventric-
ular failure and contraindication or ﬁbrinolysis therapy failure. All pts (or direct rela-
tives) signed an Informed Consent Form previously to treatment with Angiojet
thrombectomy system (Bayer HealthCare, Germany). Pre-procedure Shock Index (heart
rate/systolic arterial pressure) and pulmonary systolic pressure pre and post procedure
were obtained. Miller score was estimated after pulmonary angiogram was performed.
Primary endpoint was in-hospital death and any bleeding. During follow-up an US was
done at 3 months after discharge to assess right ventricular function and pulmonary
pressures. Long term follow-up was done to assess heart failure or functional class.
Results:Mean age was 64.5 +/- 14.3 years, 64.3% were male, with BMI>30¼71.4%,
previous malignant neoplasia in 14.2%, chronic obstructive pulmonary disease¼9.1%
and immobility¼71.4%. Pre-procedure shock index was 1.43+/-0.23. After procedure
Miller Score and systolic pulmonary pressures improved signiﬁcantly (p< 0.001 for
both). After PRT and before 30 days one patient died and no bleeding was reported.
During 25.7 +/-21 months of follow-up global mortality was 28.5% (none cardiac
related) and 2 pts showed evidence of mild cor pulmonale.
Conclusions: Percutaneous Pulmonary Rheolytic thrombectomy was safe and effec-
tive for the treatment of these high risk patients. Long-term outcome was related to the
underlying pathology.
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Background: There are limited therapuetic options for high risk patients with massive
or sub-massive pulmonary embolism. The use of ultrasound-assisted catheter directed
thrombolysis(UA-CDT) has shown to be particularly promising in various small
studies. We aimed to conduct a meta-analysis of the available published studies.
Methods: An extensive time unlimited literature search using MEDLINE, EMBASE
& Cochrane databases using MeSH key words ‘pulmonary embolism’, ‘ultrasound’
and ‘catheter-directed’ identiﬁed 7 studies including a total of 240 patients. Of these
197 patients underwent use of Ekosonic catheter directed thrombolytic therapy
(UCDT) for massive or sub-massive PE. Hemodynamic measures including mean &
systolic pulmonary artery pressure, RV-LV ratio, heart rate and cardiac index were
assessed before and after therapy. Meta-analysis was performed using Cochrane
Collaboration Review Manager(version 5.1). Effect size was estimated using random
effects model and mean difference with 95% conﬁdence intervals were calculated.
Results: One hundred and thirty patients were treated with UCDT. Massive &
bilateral PE was reported in 74(30.8%) & 152(63.3%) patients respectively. UCDT
resulted in a signiﬁcant reduction in PA systolic (mean -15.22mmHg;95% CI -21.01–
9.43) & mean PA pressures(mean -9.35mmHg;95% CI -13.03- -5.68), in addition to a
24% increase in cardiac index. The RV size, assessed by the ratio of RV to LV di-
mensions, was reduced with UCDT(mean -0.35;95% CI -0.42- -0.28), & the heart rate
decreased by 16.9 beats/min (95% CI -26.46 - -7.34). The Miller pulmonary artery
occlusion score (in 87 patients)showed a signiﬁcant reduction of 10.12 points (95% CI
-12.21 - -8.02). Thirty & 90-day all-cause mortality was 3.1% (6/197)& 4.6%(7/152)
respectively with UCDT. Recurrent events & major bleeding was reported in 2/
115(1.7%) & 7 patients(3.5%)respectively.
Conclusions: In this largest meta-analysis to-date evaluating the impact of UCDT on
massive & sub-massive PE, UCDT is associated with signiﬁcant improvements in
hemodynamic measures of RV & LV function. The procedure appears to be safe & is
associated with low 30 & 90-day mortality compared to RIETE(8.65%) and ICOPER
registries(17.4%).JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/PeTCT-514
Percutaneous Transluminal Angioplasty of the Subclavian Arteries. Long-Term
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Background: To review feasibility, safety and long-term results of subclavian artery
angioplasty.
Methods: 407 patients (males: 245, mean age: 66.1  12 y) underwent percutaneous
treatment for subclavian artery (SA) occlusive disease (stenosis: 295, occlusion: 112).
Left: 312, Right: 95, Innominate Artery: 28. Etiology: atheromatous: 397, others: 10
(Takayasu: 6) Mean % stenosis 83.4 +/- 7.8. Mean lesion length: 23.9 +/- 8.7 mm
Indications for treatment were upper limb ischemia (ULI) (n¼177) Vertebrobasilar
insufﬁciency (VBI) (n¼157), associated VBI and ULI (n¼123), coronary steal syn-
drome (n¼20) asymptomatic patients with severe coronary disease (n¼73) 39 patients
had associated Vertebral Artery stenosis, 81 carotid stenoses. 337 prevertebral lesion,
45 post vertebral, both 25. Access: femoral (n¼287), brachial (n¼81), both (n¼39).
“Pull through technique”: 8 cases. An isolated balloon angioplasty was performed in 59
cases and 348 stents were implanted (balloon expandable: 276, self expandable: 72).
Results: Technical success was obtained in 387 lesions (95 %) 100% for stenoses.
Only 92 occlusions were recanalized (82 %). Four periprocedural events occurred (1.2
%), 1 major (fatal stroke), 1 T.I.A., 2 arterial thromboses. During the follow-up (mean
follow-up: 75.7 months  38.5), we had 40 restenoses (10 %). 13 occurred following
angioplasty alone (18.8 %) and 27 following angioplasty and stent implantation (7.8 %)
(P< 0.01). 10 were treated by new angioplasty alone, 30 by repeat stent implantation.
Primary (PI) and secondary (PII) patencies on an intention to treat basis at 10-year follow-
up were 80.2 % and 86.5 % respectively. In patients without initial stent placement,
the rates were 67.5 % and 75.5 % while in those with stents, the rates rose to 91.5 % and
98.2 % (P< 0.01). PI for all recanalized lesions were 85.8 %, 79.1 % without stent, 91.8
% with stent (P < 0.04) and PII 92.8 %, 88.5 %, 98.1% respectively (P < 0.02).
Conclusions: P.T.A. is currently the treatment of choice for subclavian artery lesions.
It is a safe and effective procedure associated with low risks and good long-term
results. Stents seem to limit the restenosis rate and improve long-term results.
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Background: Erectile Dysfunction (E D) is an important and growing health problem.
It is estimated that more than 200 million men (between the age of 40 – 70 years)
suffer from ED . The real prevalence could be much higher as it is under reported and
under treated. Out of the many etiologies, 80 % of cases are because of vasculogenic
origin. Venous leak and Arterial Inﬂow problems (usually pudendal artery stenosis)
are the most common etiologies. In patients who fail PDE – 5 inhibitors therapy
(Complex ED), vasculogenic causes should be strongly suspected.
Methods: The workup is done by excluding the endocrinal, urological and psychological
causes and then subjecting these patients to a penile Doppler study (after intra cavernosal
injection of papaverine). In patients where the peak systolic penile velocity is less than
25 cm /sec, pudendal artery stenosis is strongly suspected. These patients then undergo a
selective angiography for identiﬁcation of pudendal artery stenosis. If the stenosis is
found they are subjected to super selective pudendal artery cannulation and angioplasty
or stenting using drug eluting balloon (DEB) or zatrolimus eluting stents (DES). Patients
are followed up at 3, 9, 12 months and then after every year by Duplex scans.
Results: 36 consecutive worked up patients of complex ED with pudendal artery ste-
nosis underwent pudendal artery angioplasty (with DEB or DES). The procedure was
successful in all patients There were no death, perineal or penile gangrene. The mean
penile velocity increased from base line of 16 cm / sec to 44 ,50,58 cm /sec at 3, 6, 12
months respectively. Improvement > 4 points in International Index of Erectile Func-
tions (IIEF -6 ) score at 3 , 6 and 12 months were 68 % , 75 % and 78 % respectively.
Conclusions: Angioplasty of focal stenosis of internal pudendal artery by DEB or
DES appears to be a very promising therapy for male erectile dysfunction. It is safe,
feasible and leads to sustained improvement of male erectile dysfunction in about 75
% of carefully selected cases. However still many cases are ineligible for this pro-
cedure . Larger studies are required to be able to accept it as a standard therapy to treat
male Erectile Dysfunction.
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Background: Arterial aneurysms (An) are traditionally treated surgically, but more
and more by interventional procedures with a high technical success rate, but some
problems are not solved like protection of aneurysm rupture, endoleaks, stentripheral Vascular: Miscellaneous and Other B151
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comthrombosis, collateral branch thrombosis. We used a new concept of stent, the
Multilayer Flow Modulator (MFM*) to treat An. and try to avoid some drawbacks
encountered with endografts.
Methods: This MFM* is a 3 Dimensional braided tube made of several inter-
connected layers without any covering. Our earliest in vitro (theorical simulation),
computerized Fluid dynamics, Molecular Modelization and in vivo tests demonstrated
that this MFM* reduces the velocity in the aneurismal sac up to 90% by modifying the
hemodynamic conditions. A saccular aneurysm without collateral branch will
thrombose quickly. If a collateral branch is present the ﬂow is directed towards this
branch leading to shrinkage of the aneurysm. Animal experiments show excellent
results. Moreover, as demonstrated in animal and human studies this MFM* preserves
the collateral branches allowing the possibility to cover any artery without compro-
mising the ﬂow (renal, digestive arteries, supra aortic vessels.)
Results: 44 peripheral An. (iliac:23, femoral:1, popliteal:5, renal:8, mesenteric:2, ca-
rotid: 2, Subclavian : 2, Caeliac trunk :1) were treated with the MFM* (male:31, mean
age 62+/-8 y) (57 stents ⌀ 5 to 14mm; length 40 to 120mm)were implanted to treat these
aneurysms, by femoral approach (39 cases), brachial approach (1 case), Technical
success in all patients. No complications. All An. thrombosedwith diameter reduction in
some pts. The thrombosis could take several weeks depending on the importance of
collateral branches. 6month to 36month follow upwill be presented and wewill discuss
the time needed to achieve exclusion of the An. All the side branches remained patent.
Conclusions: A new concept of stent, the MFM* (without any covering) is developed
to treat An. It opens a new approach to treat peripheral An. avoiding most of the
complications encountered with current endovascular techniques. The results obtained
seem promising. A larger study is ongoing.
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Background: Broncho –Pulmonary Fistula (BPF) occurs in 2-3 per 100, 000 popu-
lation. They could be congenital or acquired and are usually associated with Hered-
itary Hemorrhagic Telengiectasia (70 %). They could be either single or multiple,
Central ( PA to LA Fistula ) or Peripheral ( PA to PV Fistula ). Usually they are
asymptomatic ( 30 – 55 % ) but sometimes they present with cyanosis, dyspnea on
exertion, neurological symptoms (migraine, vertigo, TIA, paresis, numbness, syncope,
confusion, cerebral abscess, seizures) or haemoptysis and haemo thorax. Diagnosis is
conﬁrmed by contrast (air bubble) echocardiography or CT / conventional angiog-
raphy. Pneumonectomy, lobectomy, local excision and ligation of the pulmonary
artery used to be the available treatment but carried a signiﬁcant morbidity and
mortality. Currently Endovascular Treatment is emerging as a promising alternative
and our series is perhaps the largest one.
Methods: The diagnosis is conﬁrmed by angiography, which is performed in many
views to delineate the point of communication. Long sheath is introduced and a
Berman catheter is then advanced via the long sheath and the balloon is inﬂated. The
large ﬂow across the BPF guides the balloon catheter to the branch supplying the BPF.
The Fistula is closed either by coil embolization ( Bioptome assisted ) or Amplatzer
ASD Device or Vascular Plug ( I , II , III ). The saturations (ideally PO2) usually
normalizes after complete occlusion.
Results: N : 28 AGE : 26 +/- 3.5 YRS CENTRAL : 3/28 PERIPHERAL : 25/28 COIL
EMBOLISATION ; 8 DEVICE CLOSURE : 23 ( in 3 pts add coils were used ) TECH
SUCCESS : 100% REPEAT PROCEDURE : 5/28 SpO2 Pre op : 70 +/- 2% SpO2
Post op : 95.4 +/- 3%.
Conclusions: Most of the massive Broncho Pulmonary Fistula can be managed by
endo vascular techniques and pneumectomy or any other major surgery can be
avoided. This series of 28 successfully treated cases of Central and Peripheral Broncho
Pulmonary AVM is probably one of the largest series.
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Is The Retrieval Of IVC Filter Safe?
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Background: We wanted to study the feasibility and safety of IVC ﬁlters retrieval in
patients with DVT with pulmonary thromboembolism (PTE) with IVC ﬁlter.
Methods: We retrospectively analyzed the data of patients who presented with DVT
with massive or sub-massive PTE and were treated with catheter thrombolysis and
IVC ﬁlter (Eclipse vena caval ﬁlter from Bard company) implantation in our unit in
the year 2012 -2013. CT pulmonary angiogram, venous colour Doppler and in some
cases MR venogram was done within 24 hrs before retrieval of ﬁlter. In conventional
contrast venogram, if the ﬁlter is patent and free from signiﬁcant clot burden (< 25%
ﬁlled with thrombus), removal is then performed. Success of retrieval was deﬁned
as complete and intact whole ﬁlter removal. Complications during the procedure
of retrieval like failure to remove the ﬁlter, distortion of the ﬁlter, migration of
ﬁlter, presence of thrombus in the ﬁlter, local puncture site hematomas were noted.
Results: A total of 32 patients of DVT with acute PTE and Retrieval IVC ﬁlters
implantations, were included in this study. Out of them 22 (68.75%) males andB152 JACC Vol 64/11/Suppl B j September 13–110 (31.25%) females with mean age of 46.2  12.6 years. In 15 patients(M:F::11:4)
retrieval was attempted after complete clearance of DVT and PTE with average time
period of 45 days (minimum - 25 days, maximum – one year). Successful retrieval
was done in 13 patients (86.7%).Failed to retrieve in two patients (13.3%) in whom
the implantation duration was one year. There were no distortion or migration of ﬁlter
or local puncture site hematoma were noted. In 11 patients (11 out of 13- 84.6%) there
was a small thrombus at the apex of the ﬁlter, which were conﬁrmed by histo-pa-
thology. No fatal complication like massive PTE or embolization of ﬁlter or IVC
rupture or tears were noted.
Conclusions: The success rate of retrieval of IVC ﬁlters were good (86.7%) beyond the
window period retrieval time coated by the company (15 to 21 days).Presence of small
thrombus from the retrieved ﬁlter is very high (84.6%) without any clinical events.
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Background: Popliteal Artery Aneurysms (PA) are traditionally treated surgically.
Endovascular procedures with implantation of stent grafts or covered stents have been
proposed as an alternative to surgery. Results are encouraging but some problems
remain (aneurysm rupture, endoleaks, collateral branch thrombosis.). We used a new
concept of stent, the Multilayer Flow Modulator (MFM*) to treat aneurysms and try to
avoid some drawbacks encountered with endografts.
Methods: This MFM* is a 3 Dimensional braided tube made of several inter-
connected layers without any covering. Our earliest tests in vitro (theorical simulation,
computerized Fluid dynamics, Molecular Modelization) and in vivo demonstrate that
this MFM* reduces the velocity in the aneurismal sac up to 90% by modifying the
hemodynamic conditions. A saccular aneurysm without collateral branch will
thrombose quickly. If a collateral branch is present the ﬂow is directed towards this
branch leading to shrinkage of the aneurysm. Animal experiments show excellent
results. Moreover, as demonstrated in animal and human studies this MFM* preserves
the collateral branches allowing the possibility to cover any artery without compro-
mising the ﬂow (renal, digestive arteries, supra aortic vessels .)
Results: 5 PA were treated with the MFM* (male: 5, mean age: 65 y.) 9 stents (Ø6 to
8 mm, length 40 to 120 mm) were implanted by percutaneous ipsilateral femoral
approach through 8F sheath. Technical success in all patients. All aneurysm throm-
bosed. Mid-term follow up will be presented. No stent fracture. This MFM* seems
well indicated for this popliteal location.
Conclusions: A new concept of stent, the MFM* is developed to treat aneurysm. It
opens a new approach to treat peripheral aneurysms avoiding most of the complica-
tions encountered with current endovascular techniques. The results obtained seem
promising. A larger study is ongoing.
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Ranjan Modi1, SANJAYC PORWAL2, SURESHV PATTED3, PRABHUC HALKATI3
1kles dr. prabhakar kore hospial, belgaum, karanataka, 2KLES DR PRABHAKAR
KORE HOSPITAL, BELGAUM, Karnataka, 3KLES DR Prabhakar Kore Hospital,
Belgaum, India
Background: Juvenile nasopharyngeal angioﬁbroma (JNA) or nasopharyngeal
angioﬁbroma is an uncommon ﬁbrovascular mass arising in the nasopharynx of
prepubertal and adolescent males. The tendency of the lesion for massive bleeding
leading to life threatening complications has led to its considerable importance in
medical fraternity. Preoperative biopsy is generally avoided for fear of massive
lethal bleeding. The condition is most commonly treated by surgical excision and
the surgical approach is chosen according to the disease stage. In view of their
hypervascular nature and propensity for massive bleeding Juvenile angioﬁbromas
may beneﬁt from preoperative devascularization to reduce intraoperative blood loss.
In our cases preoperative gel foam embolization was undertaken to reduce the
vascularity.
Methods: We present a case report of 6 cases which were admitted in the otor-
rhionology and surgery department with history of nasal breathing , nasal bleeding and
vertigo. Using 7F arterial sheath through transfemoral approach multipurpose cathter
(Asahi)was passed into the common carotid via the aorta. Selective injection was
made into the vessel which helped visualization of the angiﬁbroma. A 0.014 X 190
BMW (Abott)coronary guide wire was used to gain proximity to the root of the
angiosarcoma. A Stride Microcatheter was passed over the guide wire. Selective in-
jection through the microcatheter revealed the various branches of the angioﬁbroma.
Gel foam which was prepared externally was injected through the microcatheter into
the root of the angiosarcoma. Subsequent injections revealed gel embolization of the
feeding vessel rendering the area almost avascular. The patient was subsequently
taken up for the excision surgery within 2-3 days.
Results: Post surgery,blood supply retrieved in 5-6 days.
Conclusions: We conclude preoperative angiography is mandatory for identiﬁcation
of the feeding vessels in view of preoperative embolization before surgery in all cases
of JNA . The use of the appropriate guide wire , microcatheter and proper formation of
the gel solution is necessary for the successful attainment of avascular ﬁeld
preoperatively.7, 2014 j TCT Abstracts/Peripheral Vascular: Miscellaneous and Other
